VOGLINORM R 0.5 TAB

About

Voglinorm R 0.5 Tab contains Voglibose, an oral antidiabetic agent belonging to the class of alpha-glucosidase inhibitors. Its primary mechanism of action involves reversibly inhibiting alpha-glucosidase enzymes located in the brush border of the small intestine. These enzymes are crucial for breaking down complex carbohydrates and disaccharides into absorbable monosaccharides like glucose. By slowing down this enzymatic process, Voglibose effectively delays the digestion and subsequent absorption of dietary carbohydrates.

This delayed absorption leads to a significant reduction in the rise of blood glucose levels after meals (post-prandial hyperglycemia), which is a key target in managing type 2 diabetes. Voglibose is particularly beneficial for patients who experience pronounced post-meal glucose excursions. It helps to flatten the post-meal glucose curve, contributing to better overall glycemic control and a reduction in HbA1c levels. Its action is localized to the gastrointestinal tract, resulting in minimal systemic absorption and a favorable safety profile.

Uses

• Management of type 2 diabetes mellitus.
• Reduction of post-prandial hyperglycemia.
• Adjunct to diet and exercise for glycemic control.
• Can be used alone or in combination therapy.

Directions For Use

Take this medication orally, usually immediately before or with the first bite of each main meal, as directed by your physician.

Benefits

• Effectively lowers post-meal blood glucose levels.
• Helps achieve better overall glycemic control.
• Reduces the risk of long-term diabetes complications.
• Generally does not cause weight gain.
• Can be used in combination with other antidiabetic drugs.
• Localized action in the gut minimizes systemic side effects.

Side Effects

• Abdominal pain
• Flatulence
• Diarrhea
• Nausea
• Indigestion
• Constipation
• Skin rash
• Headache
• Dizziness
• Swelling of extremities
• Increased liver enzymes (rare)
• Hypoglycemia (when used with sulfonylureas/insulin)

Safety Measures

• Alcohol - Alcohol consumption should be limited as it may affect blood sugar levels and potentially increase the risk of certain side effects.
• Pregnancy - Not recommended during pregnancy unless clearly necessary, as there is limited data on its safety. Consult a doctor.
• Breastfeeding - It is generally advised to avoid use during breastfeeding due to insufficient data on excretion into breast milk.
• Liver - Use with caution in patients with severe liver impairment; dose adjustment or avoidance may be necessary.
• Kidney - Generally considered safe in kidney impairment, but caution is advised in severe renal dysfunction.
• Lung - No specific contraindications or precautions related to lung conditions are typically noted for this medication.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.